The choice of therapeutic agent in female overactive bladder patients in real-world practice.

Hiroshi Masuda,Kosuke Mikami,Kotaro Otsuka,Kyokusin Hou,Takahito Suyama,Kazuhiro Araki,Satoko Kojima,Yukio Naya

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica（2022）

引用 0|浏览2

暂无评分

摘要

There were no significant differences in clinical characteristics of patients who were prescribed anticholinergics and β3 adrenergic agonists for OAB treatment, but a marginal difference of PVR value before treatment. The 1-year persistence rates of anticholinergic drugs and β3 adrenergic agonists were considered to be almost equivalent.

查看译文

关键词

female overactive bladder patients,therapeutic agent,real-world

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要